Vaylen Reviews 2026: Semaglutide, Oral Tablets and Tirzepatide From $83.25/mo
Updated: July 2026 · By Charly P. · 10 min read
Vaylen sells three compounded GLP-1 programs: weekly semaglutide injections from $83.25/mo, daily oral semaglutide tablets from $99/mo, and weekly tirzepatide injections from $149/mo. Every one of those headline numbers has the same string attached, and it is the reason this review exists. Each is an annualized rate on a 12-month plan billed upfront in a single charge, and you pay it before a clinician ever reads your health form. Vaylen refunds you if the answer comes back no. Understanding that sequence, and what the refund does not cover, matters more than any price on the page.
About Vaylen
Vaylen (Vaylen Health) is a cash-pay telehealth weight loss program built on compounded GLP-1 medication, sold in three formats across two molecules. Vaylen is explicit that it is not a medical provider. Clinical services are delivered by licensed U.S. clinicians through OpenLoop Health and affiliated networks, and every prescription is issued at the clinician's discretion after an individual evaluation. The company operates in all 50 states, displays a LegitScript certification, and handles patient data under HIPAA privacy practices.
The lineup covers the three decisions a GLP-1 patient actually faces. Which molecule: semaglutide, the most studied option of its generation, or tirzepatide, which Vaylen calls the strongest in its class. Whether you will use a needle: the daily dissolvable tablet exists for patients who will not. And how long you are willing to commit, which is where the pricing gets interesting. Because both molecules live on one platform, a clinician can move you from semaglutide to tirzepatide without changing providers, which is a genuine advantage over single-molecule programs.
Vaylen at a Glance
| Program type | Cash-pay online GLP-1 program, 100% remote |
|---|---|
| Medications | Compounded semaglutide and compounded tirzepatide |
| Formats | Weekly injection (both molecules) or daily oral semaglutide tablet |
| Semaglutide injection | $83.25/mo on 12 months ($999 upfront), or $224/mo monthly |
| Oral semaglutide | $99/mo on 12 months ($1,188 upfront), or $249/mo monthly |
| Tirzepatide injection | $149/mo on 12 months ($1,788 upfront), or $299/mo monthly |
| Advertised discounts | Up to 62% (semaglutide), 60% (oral), 50% (tirzepatide) |
| Consultation fee | $0, no separate charge at any point |
| Payment order | Pay first, then complete the health form |
| Clinician review | Within 24 hours of submitting your questionnaire |
| If you are declined | Full refund for that billing cycle, per Vaylen |
| Shipping | Free, discreet unmarked packaging, 1 to 3 business days |
| Included in price | Clinician review, monthly supply, shipping, 24/7 messaging, injection kit on injectables |
| Clinical services | Licensed U.S. clinicians via OpenLoop Health and affiliated networks |
| Coverage | All 50 states, LegitScript certified, HIPAA protected |
| Insurance | Not accepted, cash-pay only |
| Advertised rating | 4.8 out of 5 from verified patients |
| FDA status | Compounded medications, not FDA-approved finished products |
Vaylen's Three GLP-1 Options
Two molecules, three formats, six published prices. The molecule choice is clinical and belongs to the reviewing clinician; the format and the plan length are yours.
| Option | How You Take It | 12-Month Rate | Monthly Rate |
|---|---|---|---|
| Semaglutide injection | One weekly subcutaneous injection | $83.25/mo ($999 upfront) | |
| Oral semaglutide | One small dissolvable tablet daily | $99/mo ($1,188 upfront) | |
| Tirzepatide injection | One weekly injection, dual GLP-1 + GIP | $149/mo ($1,788 upfront) |
Two details in that table are worth pulling out. First, the needle-free option costs more, about $16 a month more than the injectable version of the same molecule on either plan, so Vaylen charges a convenience premium for going oral. Second, the advertised discount shrinks as you move up the lineup, 62% off on semaglutide, 60% on oral, 50% on tirzepatide, which means the prepay incentive is weakest exactly where the upfront cheque is largest at $1,788.
Tirzepatide is the premium tier here, and Vaylen prices it like one. It is the only option in the lineup where the month-to-month rate crosses $250, and the only one where competitors beat Vaylen's prepaid price without asking for a commitment. If tirzepatide is what you want, price it against monthly-billed alternatives before you prepay.
Vaylen Pricing: What the Headline Rates Actually Cost
None of Vaylen's headline prices is a monthly payment. Each 12-month program is billed upfront, so $83.25/mo means a single charge of $999, $99/mo means $1,188, and $149/mo means $1,788. The advertised savings check out arithmetically, twelve months of semaglutide at $224 would be $2,688, so prepaying $999 saves $1,689, right around the 62% Vaylen claims, and the same holds for the other two tiers.
| Plan | Paid Upfront | Effective Monthly | 12 Months at the Monthly Rate |
|---|---|---|---|
| Semaglutide, 12 months | $999 | $83.25/mo | |
| Oral semaglutide, 12 months | $1,188 | $99/mo | |
| Tirzepatide, 12 months | $1,788 | $149/mo |
The gap between those two columns is the whole commercial proposition, and it is a real decision rather than a trick. What deserves attention is that the cheaper number requires prepaying a full year of a medication you have not started, from a clinician who has not yet reviewed your file, for a program you cannot yet judge. Vaylen does publish a refund if you are declined at intake. It does not publish what happens to the unused portion of a prepaid year if you cancel in month three because the side effects are intolerable, and that is the term I would want in writing before sending $1,788.
How Vaylen Works: Pay, Qualify, Ship
Three steps, in an order most telehealth programs invert. Vaylen's argument for charging first is speed, your file reaches a clinician immediately rather than after a free consult queue, and the company backs it with a refund promise if the clinical answer is no.
- 1.Start the subscription
You pay before any clinical review, with no separate consultation fee. Vaylen positions this as the reason care moves faster, and you can cancel before the next billing date if you change your mind.
- 2.Complete the health form
A short questionnaire, about five minutes, submitted under HIPAA privacy practices. A board-certified U.S. clinician reviews your responses within 24 hours. If you do not qualify, Vaylen states you receive a full refund.
- 3.Medication ships to your door
Approved patients get their first supply in 1 to 3 business days in discreet unmarked packaging. Refills ship automatically each month, and care-team messaging is included rather than sold separately.
Worth being precise about what the refund does and does not cover. It protects you against the specific scenario of a clinician declining to prescribe. It is not a satisfaction guarantee, not a results guarantee, and not a stated refund for stopping treatment partway through a prepaid year. Programs that run a free evaluation first, such as altRx, never put you in the position of needing that refund in the first place, which is a structural advantage rather than a price one.
Vaylen Results Claims, Read Carefully
Vaylen advertises a 4.8 out of 5 rating from verified patients, roughly 15% average weight loss in studies for semaglutide, and over 20% for tirzepatide. The percentage claims are the only ones with published research behind them, and Vaylen's own asterisk says so, they reflect clinical studies of GLP-1 medications combined with diet and exercise, not Vaylen's patient base.
For context on where roughly 15% comes from: in the STEP 1 trial published in The New England Journal of Medicine, adults taking once-weekly semaglutide 2.4 mg alongside lifestyle intervention lost a mean of 14.9% of body weight, over 68 weeks. The tirzepatide figure traces to SURMOUNT-1, where the highest dose produced a mean loss around 21% over 72 weeks. Both are genuinely strong results. Neither is a 90-day result, and both come from trials of branded, FDA-approved medication rather than the compounded preparations Vaylen ships.
The patient figures need more caution than the trial data. Vaylen presents 26 lbs against a 90-day heading in one place and a five-month patient story in another, and the same before-and-after numbers reappear across different product pages, 34 lbs in six months is credited on both the oral tablet and tirzepatide pages, and 26 lbs in five months shows up on the injection and tirzepatide pages alike. Vaylen also discloses that some patients may have been compensated for sharing their stories. None of that is evidence of anything sinister, but it does mean the gallery carries no useful signal. Judge this program on its pricing, its refund terms, and its clinical partner.
Compounded GLP-1s: What Vaylen Is Actually Shipping
Every Vaylen medication is compounded, and Vaylen says so plainly in its own footer: compounded medications are not FDA-approved finished products and have not been evaluated by the FDA for safety, efficacy, or quality. They are prepared by licensed U.S. pharmacies against an individual prescription. The FDA explains the distinction directly: compounded drugs are not reviewed for safety or effectiveness before they reach patients, which is precisely why they can be priced the way Vaylen prices them.
The active ingredients are the same molecules found in branded products, which is what Vaylen means by “same active ingredient as leading Rx.” The preparations are not Ozempic, Wegovy, Mounjaro, or Zepbound, and no branded pathway is advertised anywhere on the program. If your requirement is an FDA-approved finished product, Vaylen is not the program to shortlist, and neither are most of the low-cost options in this category.
Vaylen Pros and Cons
Pros
- ✓Both molecules and a needle-free format on one platform, so a clinician can switch you without changing providers
- ✓$83.25/mo on the 12-month semaglutide program, among the lowest effective rates in cash-pay GLP-1 care
- ✓Oral semaglutide at $99/mo prepaid undercuts most oral GLP-1 pricing in the compounded market
- ✓A published refund if the clinician declines to prescribe, which de-risks the pay-first model
- ✓$0 consultation fee, with the clinician review bundled into every plan price
- ✓Clinician review turned around within 24 hours, and shipping in 1 to 3 business days
- ✓Injection kit, free discreet shipping, and 24/7 care-team messaging included, not upsold
- ✓LegitScript certified, HIPAA protected, licensed U.S. clinicians via OpenLoop Health in all 50 states
Cons
- ✗You pay before any clinician sees your file, the reverse of the free-evaluation model most competitors use
- ✗Every headline rate requires prepaying a full year in one charge, up to $1,788 for tirzepatide
- ✗No published terms for the unused portion of a prepaid year if you cancel mid-treatment
- ✗The needle-free tablet costs about $16/mo more than the injection of the same molecule
- ✗Prepay discounts shrink as prices rise, 50% on tirzepatide against 62% on semaglutide
- ✗All medications are compounded, not FDA-approved finished products, with no branded pathway offered
- ✗Patient before-and-after figures are reused across different product pages
- ✗Cash-pay only, with no insurance offset
The comparisons that matter run molecule by molecule. On semaglutide, Embody charges $69/mo and altRx $89/mo with no year paid in advance, so Vaylen's $83.25 is competitive only once you accept the prepay. Shed asks more again at $159/mo on twelve months, but bills it monthly rather than as a single upfront cheque. On tirzepatide the gap is sharper: altRx also starts at $149/mo and Embody at $119/mo, both billed monthly, while Vaylen's $149 requires $1,788 upfront and costs $299 without it. Against TrimRx, which costs more at $149/mo but locks your price for life so titration never raises your bill, Vaylen is the cheaper entry and TrimRx the more predictable long-term hold. Where Vaylen does win outright is the oral tablet, at $99/mo prepaid against BetterMe Rx at $195/mo for oral semaglutide, though BetterMe Rx prices its oral option at parity with its injection instead of charging a needle-free premium.
Who Vaylen Is For
Vaylen fits a decisive buyer: someone who has already accepted compounded GLP-1 medication, wants the lowest effective monthly rate, and is confident enough about qualifying to prepay a year. If you have run a GLP-1 before, know your history is clean, and intend to stay on treatment for twelve months anyway, $999 upfront for semaglutide with a bundled clinician review and no dose-based upsells is a defensible purchase. Needle aversion is the other clear case, and Vaylen's daily tablet is priced well below most oral alternatives even with its convenience premium.
It is a poor fit in two situations. If you are uncertain whether you qualify, the pay-first order means your money sits with Vaylen while you wait on a clinical decision, and a refund promise is not the same as never having paid. And if you want an FDA-approved branded medication or insurance coverage, this is the wrong category entirely, our best weight loss treatments for 2026 roundup ranks programs on those trade-offs instead of on headline price. Patients who expect to titrate up or switch molecules mid-course are better served here than at a single-molecule program, but should still confirm how a switch is billed against a prepaid plan. For the wider picture of how compounded GLP-1 programs fit together, start with the weight loss treatment guide at ExploreTreatments.com.
Bottom Line
Our Editorial Take
Vaylen is an honest version of an aggressive offer. Charging before a clinician reviews your file is the kind of thing companies usually bury; Vaylen leads with it, explains the reasoning, and attaches a refund to the one outcome that would otherwise leave a patient out of pocket. The lineup is stronger than the entry price suggests, too, both molecules plus a needle-free tablet on one platform means a plateau or an intolerance does not force you to start over somewhere else, and the bundling is clean: one price covering the consult, the medication, the kit, shipping, and 24/7 messaging.
The reservations are structural rather than suspicious, and they all point at the same place. Every headline rate is an annualized upfront charge, the terms for cancelling partway through a prepaid year are not published, and the discount is thinnest on tirzepatide where the cheque is largest. Month to month, Vaylen is not the cheap option: $299 for tirzepatide is well above what altRx and Embody charge with no commitment at all. The results marketing is also looser than the rest of the operation, with patient figures reused across product pages and studies-based percentages drawn from 68- and 72-week trials of branded medication.
Worth a serious look if you are a returning GLP-1 patient who expects to qualify and wants the cheapest credible twelve months of semaglutide, or a needle-free tablet at a price the rest of the market does not match. Take a month-to-month plan instead if you are new to GLP-1s or unsure about eligibility, and compare monthly rates elsewhere before you do. Either way, get the mid-term cancellation terms in writing at checkout.
Vaylen Alternatives
Looking for alternatives to Vaylen? Here are the top-rated GLP-1 weight loss programs we recommend:
Recommended Providers
Our editorial team’s top picks for this category.
Vaylen: Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
Still weighing your options? Compare Vaylen against our top-rated picks on the Best Weight Loss Providers list.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.